ARCH Venture Funds Update Sana Bio Stake on Dec 31, 2023

Ticker: SANA · Form: SC 13G/A · Filed: 2024-02-09T00:00:00.000Z

Sentiment: neutral

Topics: institutional-ownership, amendment, biotechnology, investor-update

TL;DR

**ARCH Venture Funds just updated their Sana Bio holdings, watch for market reaction.**

AI Summary

ARCH Venture Fund IX, L.P. and its associated entities, including ARCH Venture Fund X, L.P., filed an amended Schedule 13G/A on February 9, 2024, for their holdings in Sana Biotechnology, Inc. This filing, dated for the event on December 31, 2023, indicates a change in their beneficial ownership of Sana's Common Stock, par value $0.0001 per share. This matters to investors because ARCH Venture Funds are significant institutional investors, and changes in their holdings can signal their evolving confidence in Sana Biotechnology's future prospects.

Why It Matters

Changes in major institutional investor holdings can influence market sentiment and potentially impact Sana Biotechnology's stock price, as it reflects a shift in a sophisticated investor's position.

Risk Assessment

Risk Level: low — This is a routine amendment filing by a major investor, not indicating any immediate severe risk or opportunity.

Analyst Insight

Investors should note that a major institutional investor has updated its position, but without specific share count changes, the immediate impact is unclear. Further investigation into the exact change in ownership percentage would be prudent.

Key Numbers

Key Players & Entities

Forward-Looking Statements

FAQ

What type of filing is this and what does it signify?

This is an SC 13G/A filing, which is an amendment to a Schedule 13G. It signifies that a passive institutional investor, in this case, ARCH Venture Fund IX, L.P. and its affiliates, has updated their beneficial ownership information for Sana Biotechnology, Inc. Common Stock as of December 31, 2023.

Who are the primary reporting persons in this filing?

The primary reporting person is ARCH Venture Fund IX, L.P. The filing also lists several group members, including ARCH Venture Fund X, L.P., and individuals like Clinton Bybee, Keith Crandell, Kristina Burow, Robert Nelsen, and Steven Gillis, indicating a collective ownership group.

What is the subject company of this filing?

The subject company is Sana Biotechnology, Inc., with a Central Index Key (CIK) of 0001770121 and a CUSIP number for its Common Stock of 799566104.

What was the 'Date of Event Which Requires Filing of This Statement'?

The 'Date of Event Which Requires Filing of This Statement' was December 31, 2023, meaning the reported ownership change occurred on or before this date.

Which rule under the Securities Exchange Act of 1934 is this Schedule 13G filed under?

This Schedule 13G/A is filed under Rule 13d-1(d) of the Securities Exchange Act of 1934, as indicated by the checked box on the cover page.

Filing Stats: 3,749 words · 15 min read · ~12 pages · Grade level 10.7 · Accepted 2024-02-09 17:35:30

Key Financial Figures

Filing Documents

From the Filing

SC 13G/A 1 arch-sch13g_18793.htm ARCH VENTURE FUND IX, L.P. - SANA BIOTECHNOLOGY -- SCH 13G/A(#2) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Sana Biotechnology, Inc. (Name of Issuer) Common Stock par value $0.0001 per share (Title of Class of Securities) 799566104 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 799566104 13G Page 2 of 25 Pages 1 NAMES OF REPORTING PERSON(S) ARCH Venture Fund IX, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 0 6 SHARED VOTING POWER 44,042,500 7 SOLE DISPOSITIVE POWER 0 8 SHARED DISPOSITIVE POWER 44,042,500 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 44,042,500 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 22.3% 12 TYPE OF REPORTING PERSON PN CUSIP No. 799566104 13G Page 3 of 25 Pages 1 NAMES OF REPORTING PERSON(S) ARCH Venture Fund IX Overage, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 0 6 SHARED VOTING POWER 44,042,500 7 SOLE DISPOSITIVE POWER 0 8 SHARED DISPOSITIVE POWER 44,042,500 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 44,042,500 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 22.3% 12 TYPE OF REPORTING PERSON PN CUSIP No. 799566104 13G Page 4 of 25 Pages 1 NAMES OF REPORTING PERSON(S) ARCH Venture Fund X, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 0 6 SHARED VOTING POWER 44,042,500 7 SOLE DISPOSITIVE POWER 0 8 SHARED DISPOSITIVE POWER 44,042,500 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 44,042,500 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 22.3% 12 TYPE OF REPORTING PERSON PN CUSIP No. 799566104 13G Page 5 of 25 Pages 1 NAMES OF REPORTING PERSON(S) ARCH Venture Fund X Overage, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 0 6 SHARED VOTING POWER 44,042,500 7 SOLE DISPOSITIVE POWER 0 8 SHARED DISPOSITIVE POWER 44,042,500 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 44,042,500 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 22.3% 12 TYPE OF REPORTING PERSON PN CUSIP No. 799566104 13G Page 6 of 25 Pages 1 NAMES OF REPORTING PERSON(S) ARCH Venture Partners IX, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 0 6 SHARED VOTING POWER 44,042,500 7 SOLE DISPOSITIVE POWER 0 8 SHARED DISPOSITIVE POWER 44,042,500 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 44,042,500 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 22.3% 12 TYPE OF REPORTING PERSON PN CUSIP No. 799566104 13G Page 7 of 25 Pages 1 NAMES OF REPORTING PERSON(S) ARCH Venture Partners IX Overag

View on Read The Filing